Effect of autogenic training on quality of life and symptoms in people living with HIV: A mixed method randomized controlled trial
Quality of life of people living with HIV is strongly affected by sleep problems, fatigue, pain, anxiety, and depression symptoms. This study set out to evaluate the effects of autogenic training (AT) on quality of life and symptoms within this population. A mixed method randomized controlled trial...
Gespeichert in:
Veröffentlicht in: | Complementary therapies in clinical practice 2023-02, Vol.50, p.101716-101716, Article 101716 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Quality of life of people living with HIV is strongly affected by sleep problems, fatigue, pain, anxiety, and depression symptoms. This study set out to evaluate the effects of autogenic training (AT) on quality of life and symptoms within this population.
A mixed method randomized controlled trial was conducted. Participants were randomly assigned to either the AT group (n = 32) or the control group (CG) (n = 31). Quality of life and symptoms were measured in both groups three times: prior to intervention (T0), immediately after intervention (T3), and three months after intervention (T6). Fourteen individual interviews were conducted.
Results show a significant improvement in social and mental dimensions of quality of life for the two groups at T6. They also show a significant improvement in sleep for AT participants at T3. Qualitative results are consistent with quantitative ones.
AT seems to improve sleep quality and could improve some dimensions of quality of life and other symptoms among people living with HIV. Further studies are needed to confirm these results.
NCT01901016.
•Quality of life of people living with HIV is affected by sleep problems, fatigue, pain, anxiety, and depression symptoms.•Studies show co-occurrence of these symptoms among this population.•AT seems to improve sleep quality and could improve other symptoms and quality of life among people living with HIV. |
---|---|
ISSN: | 1744-3881 1873-6947 |
DOI: | 10.1016/j.ctcp.2022.101716 |